drugset / Trial / NCT03661385

Nitric Oxide During Bypass for Arterial Switch Operation

NCT03661385

Phase 3 Completed 300 enrolled Murdoch Childrens Research Institute
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This trial will test if adding nitric oxide (NO) gas to the cardiopulmonary bypass (CPB) circuit in infants undergoing an arterial switch operation (ASO) for Transposition of the Great Arteries (TGA) changes the incidence of major postoperative adverse events (AEs). Major postoperative AEs include cardiac arrest, emergency chest opening, use of ECMO (machine that acts as an artificial heart and lung during surgery), and death. Participants will be randomised to receive oxygen plus nitric oxide (intervention arm) or oxygen without nitric oxide (control arm) during CPB.

Timeline

Start
2018-07-11
Primary completion
2022-03-23
Completion
2023-04-23

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nitric Oxide Other / unclassified 20 ppm Other